山西证券给予开能健康增持评级，业绩稳健，大健康业务潜力巨大

Group 1 - The core viewpoint of the report is that Shanxi Securities has given a "buy" rating to Kaineng Health (300272.SZ) based on its strong performance in high-margin terminal business and services, which are growing the fastest [1] - The report highlights that the Yuanneng Group focuses on third-party cell storage as its core business and is expanding into key health-related sectors [1] - The scale effect is driving improvements in profitability for Kaineng Health [1] Group 2 - The pet industry is experiencing a significant boom, with a market size of 300 billion yuan, leading to positive performance among listed companies in the sector [1]